Researchers developed SAMP-Score, a machine learning tool that uses cell image morphology to screen for compounds inducing senescence in p16-positive cancer cells.
Key Details
- 1SAMP-Score leverages high-content microscopy images and morphological profiles (SAMPs) to classify cell senescence.
- 2The system screened over 10,000 compounds in p16-positive basal-like breast cancer (BLBC) cells.
- 3It identified QM5928 as a compound that consistently induced cancer cell senescence without killing normal cells.
- 4QM5928 was effective even in cancers resistant to drugs like palbociclib, which are often problematic in high p16-expressing cancers.
- 5The study demonstrates SAMP-Score's ability to detect nuanced morphological changes via AI analysis.
- 6SAMP-Score is openly available to the research community on GitHub.
Why It Matters
This study highlights how AI-driven image analysis can identify promising new drug candidates by detecting subtle cellular changes that traditional methods might miss. Such advances could accelerate development of therapies, particularly for cancers that lack clear biomarkers and respond poorly to existing treatments.
Source
EurekAlert
Related News
•EurekAlert
Dynamic AI Models Provide Early Disease Warnings from Health Data
AI-driven dynamic models may predict disease tipping points earlier by analyzing changes in health data, including imaging.
•EurekAlert
Mount Sinai Develops AI Model to Personalize CPAP's Cardiovascular Impact
Mount Sinai has developed a machine learning model forecasting the cardiovascular risk impact of CPAP in obstructive sleep apnea patients.
•EurekAlert
AI Model Accurately Predicts Recurrence After Barrett’s Esophagus Therapy
Researchers created an AI tool that predicts recurrence of Barrett’s esophagus following endoscopic eradication therapies with greater than 90% accuracy.